Trials / Completed
CompletedNCT01703520
Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).
Finasteride and Male Breast Cancer - A Register-Based Nested Case-Control Study in Denmark, Finland, Norway, and Sweden
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 575,216 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Male
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to investigate the potential association between finasteride (MK-0906) exposure and the development of breast cancer in men residing in Denmark, Sweden, Finland, and Norway from data in national registries. The primary hypothesis of this study is that the previously reported increased incidence of male breast cancer among finasteride users is explained by confounding factors.
Conditions
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2017-11-30
- Completion
- 2017-11-30
- First posted
- 2012-10-10
- Last updated
- 2024-05-10
Source: ClinicalTrials.gov record NCT01703520. Inclusion in this directory is not an endorsement.